The anti-fentanyl vaccine currently under development promises to be a critical tool in preventing overdoses, with human trials anticipated to begin in 2025.
Developed over 36 years of research, the vaccine aims to combat the epidemic of fentanyl overdoses that resulted in 74,702 deaths in 2023 alone.
Despite some improvements in treating substance use disorders, the reality remains grim with consistent relapse and overdose rates showing the dire need for innovative solutions.
The historical challenges faced by vaccine immunotherapy in human trials raise cautious optimism about the approaching human testing of the anti-fentanyl vaccine.
#substance-use-disorders #fentanyl-vaccine #overdose-prevention #vaccination-research #public-health
Collection
[
|
...
]